Expertise in
23
conditions

Krzysztof Kalwak

213 Borowska St, 
Wroclaw, DS, PL 
Expertise in
23
conditions
213 Borowska St, 
Wroclaw, DS, PL 

Overview

Krzysztof Kalwak practices practicing medicine in Wroclaw, Poland.

Mr. Kalwak is highly rated in 23 conditions, according to our data. His clinical expertise encompasses Atelosteogenesis Type 1, Nijmegen Breakage Syndrome, Graft Versus Host Disease (GvHD), Bone Marrow Transplant, and Bone Graft.

He is actively involved in clinical research, co-authoring 210 peer reviewed articles and participating in 2 clinical trials.

Gender

Male

Locations

213 Borowska St, Wroclaw, DS 50556, Poland
Other Locations
44 Bujwida St, Wroclaw, DS 50368, Poland

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase II Study of Blincyto in Children With CD19+ Precursor B-lineage ALL and MRD-Positivity Before and/or Following First Allogeneic HSCT
A Phase II Study of Blincyto in Children With CD19+ Precursor B-lineage ALL and MRD-Positivity Before and/or Following First Allogeneic HSCT
Enrollment Status: Terminated
Publish Date: January 16, 2024
Intervention Type: Drug
Study Drug: Blinatumomab
Study Phase: Phase 2
Study to Assess the Safety, Overall Tolerability, and Antiviral Activity of Brincidofovir Versus Standard of Care for Treatment of Adenovirus in High-risk Pediatric Allogeneic Hematopoietic Transplant Recipients
Study to Assess the Safety, Overall Tolerability, and Antiviral Activity of Brincidofovir Versus Standard of Care for Treatment of Adenovirus in High-risk Pediatric Allogeneic Hematopoietic Transplant Recipients
Enrollment Status: Terminated
Publish Date: January 25, 2021
Intervention Type: Other, Drug
Study Phase: Phase 2
View 1 Less Clinical Trial

210 Total Publications

Landscape Assessment to Characterize Baseline Access and Multilevel Barriers to IMProve Access to Chimeric Antigen Receptor T-Cell CD19 Therapy for Pediatric B-ALL (IMPACT study) Across Europe.
Landscape Assessment to Characterize Baseline Access and Multilevel Barriers to IMProve Access to Chimeric Antigen Receptor T-Cell CD19 Therapy for Pediatric B-ALL (IMPACT study) Across Europe.
Journal: JCO global oncology
Published: June 04, 2026

Frequently Asked Questions about Krzysztof Kalwak

Is Krzysztof Kalwak a top-rated expert for Bone Marrow Transplant?

MediFind is an objective health platform that identifies experts based on real-world data. Krzysztof Kalwak is classified as an Elite expert for Bone Marrow Transplant, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Krzysztof Kalwak participate in research or clinical trials?

Yes. Krzysztof Kalwak has published 210 articles and abstracts on conditions like Bone Marrow Transplant. You can view a list of Krzysztof Kalwak's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Kalwak's expertise for a condition
ConditionClose
View All 15 Advanced Conditions
View All 57 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile